EUVIMEDEUVIMED entdecken
Crossref

Comparison of thalidomide versus apatinib for prevention of camrelizumab-induced reactive cutaneous capillary endothelial proliferation: a retrospective study

Geng Song, Fei-Fei Zhang, Huai-Dong Cheng

SCIREA Journal of Clinical Medicine · 2023

DOI: 10.54647/cm321042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SCIREA Journal of Clinical Medicine, 2023. Verfasst von Geng Song und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Song, G., Zhang, F., & Cheng, H. (2023). Comparison of thalidomide versus apatinib for prevention of camrelizumab-induced reactive cutaneous capillary endothelial proliferation: a retrospective study. SCIREA Journal of Clinical Medicine. https://doi.org/10.54647/cm321042

Vancouver

Song G, Zhang F, Cheng H. Comparison of thalidomide versus apatinib for prevention of camrelizumab-induced reactive cutaneous capillary endothelial proliferation: a retrospective study. SCIREA Journal of Clinical Medicine. 2023. doi:10.54647/cm321042

BibTeX
@article{Song2023,
  author = {Song, Geng and Zhang, Fei-Fei and Cheng, Huai-Dong},
  title = {Comparison of thalidomide versus apatinib for prevention of camrelizumab-induced reactive cutaneous capillary endothelial proliferation: a retrospective study},
  journal = {SCIREA Journal of Clinical Medicine},
  year = {2023},
  doi = {10.54647/cm321042}
}
Kostenlos starten →